The need for pharmaceutical manufacturers to act now in order to meet the requirements of the EU Falsified Medicines Directive (FMD) and still be able to sell their products throughout Europe after 2017, will be the key theme of a seminar at the Total Processing & Packaging exhibition at the NEC in June. Presented by 3C Integrity managing director Christoph Krähenbühl in association with pharmaceutical coding specialist Sunala, the seminar will demonstrate how, although certain aspects of the directive will not be known until 2014, there is enough information available for companies to begin their preparations now and that those who delay for too long run the risk of not being ready in time.
Tel: 01942 674440
